State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
-3.65%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.2B
AUM Growth
-$3.58B
(-6.9%)
Cap. Flow
-$581M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
2,541
New
398
Increased
831
Reduced
708
Closed
271
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$809M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$244M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$185M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$104M |
| 5 |
S&P Global
SPGI
|
+$75.1M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$199M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$154M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$118M |
| 4 |
Elevance Health
ELV
|
+$116M |
| 5 |
Microsoft
MSFT
|
+$88.6M |
Sector Composition
| 1 | Technology | 23.12% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Veru
VERU
$52.2M
| $747K | ﹤0.01% |
15,470
+7,530
| +95% | +$364K |
|
|
ENDP
1702
DELISTED
Endo International plc
ENDP
| $747K | ﹤0.01% |
323,200
| – | – |
|
|
RUBY
1703
DELISTED
Rubius Therapeutics, Inc
RUBY
| $741K | ﹤0.01% |
134,400
+55,100
| +69% | +$304K |
|
1704
CEMIG Preferred Shares
CIG
$5.84B
| $740K | ﹤0.01% |
388,232
| – | – |
|
1705
Aecom
ACM
$16.9B
| $739K | ﹤0.01% |
9,621
-6,965
| -42% | -$535K |
|
1706
Castle Biosciences
CSTL
$660M
| $736K | ﹤0.01% |
16,400
| – | – |
|
|
SOHU
1707
Sohu.com
SOHU
$481M
| $732K | ﹤0.01% |
43,527
-32,422
| -43% | -$545K |
|
1708
Arcturus Therapeutics
ARCT
$490M
| $731K | ﹤0.01% |
27,100
-3,531
| -12% | -$95.2K |
|
|
X
1709
DELISTED
US Steel
X
| $726K | ﹤0.01% |
19,245
-13,276
| -41% | -$501K |
|
1710
Avidity Biosciences
RNA
$5.28B
| $724K | ﹤0.01% |
39,200
| – | – |
|
1711
InMode
INMD
$970M
| $720K | ﹤0.01% |
19,498
+9,998
| +105% | +$369K |
|
1712
Quince Therapeutics
QNCX
$84.9M
| $720K | ﹤0.01% |
116,300
+95,200
| +451% | +$589K |
|
1713
AnaptysBio
ANAB
$649M
| $713K | ﹤0.01% |
28,800
-8,900
| -24% | -$220K |
|
|
TVRD
1714
Tvardi Therapeutics, Inc. Common Stock
TVRD
$332M
| $713K | ﹤0.01% |
1,631
| – | – |
|
|
CMRX
1715
DELISTED
Chimerix, Inc.
CMRX
| $709K | ﹤0.01% |
154,900
+37,300
| +32% | +$171K |
|
1716
Karyopharm Therapeutics
KPTI
$57.6M
| $706K | ﹤0.01% |
6,387
| – | – |
|
1717
PMV Pharmaceuticals
PMVP
$65.2M
| $706K | ﹤0.01% |
33,900
| – | – |
|
1718
Carriage Services
CSV
$671M
| $699K | ﹤0.01% |
13,100
+6,600
| +102% | +$352K |
|
1719
Kodak
KODK
$485M
| $695K | ﹤0.01% |
+106,100
| New | +$695K |
|
|
EGRX
1720
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $693K | ﹤0.01% |
14,000
| – | – |
|
|
CGC
1721
Canopy Growth
CGC
$434M
| $690K | ﹤0.01% |
9,085
-1,334
| -13% | -$101K |
|
|
GOEV
1722
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $690K | ﹤0.01% |
272
| – | – |
|
1723
Rigel Pharmaceuticals
RIGL
$678M
| $684K | ﹤0.01% |
22,870
-2,450
| -10% | -$73.3K |
|
|
ALBO
1724
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $680K | ﹤0.01% |
22,800
| – | – |
|
|
GRTS
1725
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $678K | ﹤0.01% |
164,500
+81,600
| +98% | +$336K |
|